Amylyx Pharmaceuticals Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

136

Market Cap

1.67B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	87.37M	-293.42M	-77.06%
Dec 31, 2023	380.79M	358.56M	1,612.94%
Dec 31, 2022	22.23M	21.95M	7,700.00%
Dec 31, 2021	285.00K	-365.00K	-56.15%
Dec 31, 2020	650.00K	-776.00K	-54.42%
Dec 31, 2019	1.43M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Bausch Health Companies	10.53B
Perrigo Company	4.18B
Phibro Animal Health	1.50B
Prestige Consumer Healthcare	1.09B
ANI Pharmaceuticals	923.71M
BioCryst Pharmaceuticals	885.72M
Supernus Pharmaceuticals	776.83M
Alvotech	562.04M

Revenue Rankings

AMLX News

6 days ago - Amylyx Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
8 days ago - Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026 - Business Wire
12 days ago - Amylyx Pharmaceuticals Transcript: AGM 2026 - Transcripts
4 weeks ago - Amylyx announces publication of Phase 2 open-label HELIOS trial data - TheFly
4 weeks ago - Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation - Business Wire
4 weeks ago - Amylyx Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
5 weeks ago - Amylyx sees cash runway into 2028 - TheFly
5 weeks ago - Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts

More News